NEW: Regeneron Pharmaceuticals says it provided "a single 8 gram dose of REGN-COV2," an investigational Covid-19 therapy, in response to a "compassionate use" request from the president’s physicians

 

NEW: Regeneron Pharmaceuticals says it provided "a single 8 gram dose of REGN-COV2," an investigational Covid-19 therapy, in response to a "compassionate use" request from the president’s physicians - @CNBC

— NBC News (@NBCNews) October 2, 2020